| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.9 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | 0.022 | 0.9 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.0049 | 0.9 |